INT236457

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.31
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 3
Disease Relevance 2.55
Pain Relevance 0.35

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nucleus (MVP) cytoplasm (MVP)
MVP (Homo sapiens)
Pain Link Frequency Relevance Heat
Analgesic 12 90.32 High High
dexamethasone 3 71.88 Quite High
palliative 9 59.28 Quite High
Pain 12 58.96 Quite High
opiate 6 46.04 Quite Low
Angina 9 5.00 Very Low Very Low Very Low
Thoracotomy 3 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Mitral Valve Prolapse 144 100.00 Very High Very High Very High
Infection 3 99.40 Very High Very High Very High
Constipation 3 97.60 Very High Very High Very High
Death 12 94.32 High High
Tinnitus 3 93.12 High High
Lung Cancer 75 92.32 High High
Malignant Neoplastic Disease 30 88.36 High High
Pleural Effusion 6 81.60 Quite High
Cancer 39 73.24 Quite High
Vomiting 3 70.92 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Five patients (three ASC plus MVP, two ASC plus vinorelbine) were still alive more than 4 years after randomisation.
Localization (vinorelbine) of MVP associated with mitral valve prolapse
1) Confidence 0.31 Published 2008 Journal Lancet Section Body Doc Link PMC2431123 Disease Relevance 1.18 Pain Relevance 0.14
For patients allocated to ASC plus MVP, the criteria also included no renal toxic effects, severe constipation, or ototoxicity.
Localization (allocated) of MVP associated with mitral valve prolapse and constipation
2) Confidence 0.31 Published 2008 Journal Lancet Section Body Doc Link PMC2431123 Disease Relevance 0.49 Pain Relevance 0.15
Only five (4%) patients who were allocated to ASC plus MVP did not receive any protocol chemotherapy (one patient refused, two progressed, one died before starting, and one was given carboplatin, rather than cisplatin, because of tinnitus).
Localization (allocated) of MVP associated with tinnitus and mitral valve prolapse
3) Confidence 0.31 Published 2008 Journal Lancet Section Body Doc Link PMC2431123 Disease Relevance 0.87 Pain Relevance 0.06

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox